Arkolith/Insider Trading/TCON/Form 4

Opaleye Management Inc.

10% OwnerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed Apr 25, 2022
Net Buying
Open-Market Buys
$118K
Open-Market Sells
$0
Net Open-Market Flow
$118K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 25, 2022Buy(P)10K$2.18$22K2.9M
Apr 25, 2022Buy(P)777$2.18$2K335K
Apr 22, 2022Buy(P)38K$2.24$84K2.9M
Apr 22, 2022Buy(P)4K$2.24$10K334K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-010879) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML